{
    "organizations": [],
    "uuid": "d444f8d5f3ccf9f2c6d3b5bcbf860841b4f536ea",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-al-kindi-for-production-of-veterin/brief-al-kindi-for-production-of-veterinary-vaccines-drugs-fy-profit-rises-idUSFWN1QB083",
    "ord_in_thread": 0,
    "title": "BRIEF-Al Kindi For Production Of Veterinary Vaccines Drugs FY Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - AL KINDI FOR PRODUCTION OF VETERINARY VACCINES DRUGS:\n* FY NET SURPLUS 204.5 MILLION DINARS VERSUS 43.9 MILLION DINARS YEAR AGO Source: ( bit.ly/2CzJ4aS ) Further company coverage:\n ",
    "published": "2018-02-21T18:10:00.000+02:00",
    "crawled": "2018-02-22T18:19:38.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "al",
        "kindi",
        "production",
        "veterinary",
        "vaccine",
        "drug",
        "fy",
        "net",
        "surplus",
        "million",
        "dinar",
        "versus",
        "million",
        "dinar",
        "year",
        "ago",
        "source",
        "company",
        "coverage"
    ]
}